Literature DB >> 17000400

Impact of Acinetobacter infection on the mortality of burn patients.

Michael C Albrecht1, Michael A Albrecht, Matthew E Griffith, Clinton K Murray, Kevin K Chung, Edward E Horvath, John A Ward, Duane R Hospenthal, John B Holcomb, Steven E Wolf.   

Abstract

BACKGROUND: Acinetobacter calcoaceticus-baumannii complex (Acb) is recognized as an important cause of nosocomial infections. Although Acb can be associated with multidrug resistance, its impact on mortality in burn patients has not been fully elucidated. STUDY
DESIGN: In a retrospective cohort study assessing medical records and microbiology laboratory data at a US military tertiary care burn center, we evaluated all patients admitted to the burn center between January 2003 and November 2005. Data collected included age, severity of burn, comorbidities, length of stay, and survival to hospital discharge. In addition, microbiology data were reviewed to determine which patients were infected with Acb during this time frame. These data were then used to compare patients infected with Acb to patients not infected. Multivariate analysis using logistic regression was performed to determine which patient characteristics were associated with increased mortality.
RESULTS: There were 802 patients included in the study. Fifty-nine patients met the case definition for infection. An additional 52 patients were found to be colonized with Acb. Patients with Acb infection had more severe burns and comorbidities, and had longer lengths of stay compared with patients without Acb or those with Acb colonization. Mortality in infected patients was higher compared with those without infection (relative risk = 2.86, p = 0.001). On multivariate analysis, infection with Acb was not statistically associated with mortality.
CONCLUSIONS: Multidrug-resistant Acb is a common cause of nosocomial infection in the burn patient population. Despite this, it does not independently affect mortality.

Entities:  

Mesh:

Year:  2006        PMID: 17000400     DOI: 10.1016/j.jamcollsurg.2006.06.013

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  27 in total

Review 1.  Acinetobacter pneumonia: a review.

Authors:  Joshua D Hartzell; Andrew S Kim; Mark G Kortepeter; Kimberly A Moran
Journal:  MedGenMed       Date:  2007-07-05

2.  Colistin heteroresistance in acinetobacter and its association with previous colistin therapy.

Authors:  Joshua S Hawley; Clinton K Murray; James H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2007-10-22       Impact factor: 5.191

Review 3.  Multidrug-resistant organisms in military wounds from Iraq and Afghanistan.

Authors:  Jason H Calhoun; Clinton K Murray; M M Manring
Journal:  Clin Orthop Relat Res       Date:  2008-03-18       Impact factor: 4.176

4.  Clinical characteristics and outcomes of bacteremia due to different genomic species of Acinetobacter baumannii complex in patients with solid tumors.

Authors:  M-C Chiang; S-C Kuo; S-J Chen; S-P Yang; Y-T Lee; T-L Chen; C-P Fung
Journal:  Infection       Date:  2011-09-02       Impact factor: 3.553

5.  Prevalence of beta lactamase producing species of pseudomonas and acinetobacter in pediatric burn patients.

Authors:  B Sobouti; N Khosravi; A Daneshvar; S Fallah; M Moradi; Y Ghavami
Journal:  Ann Burns Fire Disasters       Date:  2015-09-30

6.  Risk Factors and Outcomes Associated with Multidrug-Resistant Acinetobacter baumannii upon Intensive Care Unit Admission.

Authors:  Natalia Blanco; Anthony D Harris; Clare Rock; J Kristie Johnson; Lisa Pineles; Robert A Bonomo; Arjun Srinivasan; Melinda M Pettigrew; Kerri A Thom
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

7.  Multi-drug resistant Acinetobacter species from various clinical samples in a tertiary care hospital from South India.

Authors:  Vijayan Sivaranjani; Sivaraman Umadevi; Sreenivasan Srirangaraj; Arunava Kali; Ks Seetha
Journal:  Australas Med J       Date:  2013-12-31

8.  Laboratory-based evaluation of MDR strains of Pseudomonas in patients with acute burn injuries.

Authors:  Hong-Tu Zhang; Hui Liu
Journal:  Int J Clin Exp Med       Date:  2015-09-15

9.  Acinetobacter pneumonia: Is the outcome different from the pneumonias caused by other agents.

Authors:  Ebru Cakir Edis; Osman N Hatipoglu; Ozlem Tansel; Necdet Sut
Journal:  Ann Thorac Med       Date:  2010-04       Impact factor: 2.219

Review 10.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.